Patients should be counseled to modify risk factors that can precipitateÂ coronary artery vasospasm (CAVS) such as smoking. Treatment should be targeted in initiating and maintaining maximum tolerated doses of calcium channel blockers. Patients should be encouraged about medication compliance and the risks of recurrent CAVS that can occur with medication non-compliance.